{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:12:37Z","timestamp":1791267157957,"version":"4.1.0"},"reference-count":113,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Targets"],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.1080\/14728222.2026.2671678","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:57:09Z","timestamp":1778252229000},"page":"451-461","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Targeting the OPA1 pathway in Autosomal Dominant Optic Atrophy (ADOA): 25\u2009years from gene discovery to therapeutic strategy"],"prefix":"10.1080","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1319-3062","authenticated-orcid":false,"given":"Marcel V.","family":"Alavi","sequence":"first","affiliation":[{"name":"712 North Inc","place":["Berkeley, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"54","key":"e_1_3_6_3_1","first-page":"1","article-title":"Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families","volume":"164","author":"Kjer P.","year":"1959","unstructured":"Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol Suppl. 1959;164(Supp 54):1\u2013147. PMID: 13660776.","journal-title":"Acta Ophthalmol Suppl"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2010.11.002"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701591"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2003.10.003"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/26330040211029037"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00099-0"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3192"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61423-7"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2010.07.015"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.4.423"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(80)35247-0"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1979.01020020248013"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.30794"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.06.011"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-5-25"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-8-32"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1424928"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.10.32"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.35.10.793"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.12.038"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.062570"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.39.8.e47"},{"issue":"6","key":"e_1_3_6_25_1","first-page":"1190","article-title":"Linkage analysis in dominant optic atrophy","volume":"35","author":"Kivlin JD","year":"1983","unstructured":"Kivlin JD, Lovrien EW, Bishop DT, et al. Linkage analysis in dominant optic atrophy. Am J Hum Genet. 1983;35(6):1190\u20131195. PMID: 6580816.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1996.tb00672.x"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.13.1369"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.12.038"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/79944"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/79936"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253987"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad080"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac395"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae324"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genet-110410-132529"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14543"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12835"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13588"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.681326"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50973"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201308006"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3560"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm079"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws303"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm005"},{"key":"e_1_3_6_46_1","unstructured":"Leiden Open Variation Database (LOVD) - OPA1 [Database]. Mitodyn.org; 2003\u20132026. [cited 2025 Jan 15]. Available from: https:\/\/databases.lovd.nl\/shared\/genes\/OPA1"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu184"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu234"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq007"},{"key":"e_1_3_6_50_1","first-page":"292","article-title":"Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy","volume":"19","author":"Chen Y","year":"2013","unstructured":"Chen Y, Jia X, Wang P, et al. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy. Mol Vis. 2013;19:292\u2013302. PMID: 23401657.","journal-title":"Mol Vis"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.04.018"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.13.1359"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm272"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm298"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00665-2"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12985"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3013"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1219855"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1372-3"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1919116117"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50294"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2009.89"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e09-03-0252"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.05.007"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.06.025"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep13989"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2421-9"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.02.011"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.11.049"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-019-0345-2"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102119"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.08.015"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.04.016"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx4562"},{"key":"e_1_3_6_75_1","unstructured":"NCT 06970106: safety of single and repeat dose of PYC-001 eye injections in people with Autosomal Dominant Optic Atrophy (PYC-001-CL-102) [Clinical Trial]. 2025 [cited 2026 Jan 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06970106"},{"key":"e_1_3_6_76_1","unstructured":"Chai T Landin D Utama S et al. PYC-001 a peptide-conjugated phosphorodiamidate morpholino oligomer for the treatment of Autosomal Dominant Optic Atrophy [Poster]. PYC Therapeutics; 2023 [cited 2025 Jul 22]. [Poster] https:\/\/pyctx.com\/wp-content\/uploads\/2023_ADOA-OTS-Poster_FINAL-1.pdf"},{"key":"e_1_3_6_77_1","unstructured":"EU CT 2023-506290-35-00: a study to investigate the safety tolerability and exposure of single doses of the study medicine STK-002 in patients with Autosomal Dominant Optic Atrophy (ADOA) [Clinical Trial]. 2023 [cited 2026 Jan 16]. Available from: https:\/\/euclinicaltrials.eu\/ctis-public\/view\/2023-506290-35-00"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2024.0022"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20838-8"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136364"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.10.019"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060955"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2012.70"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.01.002"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2076-4"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2078-2"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106063"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32177"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809288"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157504"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.220871"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0116"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201507022"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00036.2014"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan4935"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2019.03.001"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E21-04-0191"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.1c00350"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.180582"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2023.02.002"},{"key":"e_1_3_6_101_1","unstructured":"EudraCT 2019-001493-28: Raxone\u00ae treatment for patients with dominant optic atrophy due to OPA1 gene mutation [Clinical Trial]. 2019 [cited 2026 Jan 16]. Available from: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2019-001493-28\/results"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1080\/01658107.2023.2251575"},{"key":"e_1_3_6_103_1","unstructured":"ACTRN12621000826842: phase II randomised double blinded placebo-controlled proof-of-concept study of the efficacy of idebenone in dominant optic atrophy [Clinical Trial]. 2021 [cited 2026 Jan 16]. Available from: https:\/\/anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12621000826842"},{"key":"e_1_3_6_104_1","unstructured":"NCT 06007391: tolerance and efficacy nicotinamide (Vitamin B3) in dominant optic atrophy OPA1 (NICOPA1-TOL) [Clinical Trial]. 2024 [cited 2026 Jan 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06007391"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2025.01.002"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.21037\/sci.2019.11.01"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168380"},{"key":"e_1_3_6_108_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17821-1"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108901"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI191315"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101160"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-21987"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15102"},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00655-y"},{"key":"e_1_3_6_115_1","unstructured":"FDA guidance for industry: use of Bayesian methodology in clinical trials of drugs and biological products [Draft Guidance]. 2026 Jan [cited 2026 Jan 16]. Available from: https:\/\/www.regulations.gov\/docket\/FDA-2025-D-3217"}],"container-title":["Expert Opinion on Therapeutic Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728222.2026.2671678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:10:08Z","timestamp":1780305008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728222.2026.2671678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":113,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1080\/14728222.2026.2671678"],"URL":"https:\/\/doi.org\/10.1080\/14728222.2026.2671678","relation":{},"ISSN":["1472-8222","1744-7631"],"issn-type":[{"value":"1472-8222","type":"print"},{"value":"1744-7631","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}